Investing.com -- Corvus Pharmaceuticals (NASDAQ:CRVS) stock surged 48% Tuesday morning following the company’s announcement ...
56 分钟
Corvus Pharmaceuticals Announces Positive Data from Cohort 4 Confirming Results for Placebo ...
Cohort 4 data demonstrated positive safety and efficacy results, including additional clinical benefit observed following ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈